CoChat

Efficacy of Myo-inositol on Anthropometric, Metabolic, and Endocrine Outcomes in PCOS Patients: a Meta-analysis of Randomized Controlled Trial

Jethaliya, Hardik, Gajjar, Nirva, Patel, Vrushank, Deshpande, Shrikalp, Patel, Roshni · 2022 · Reproductive Sciences

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Abstract

Polycystic ovary syndrome (PCOS) is a common cause of female infertility, affecting 5-10% of women of reproductive age. Many studies have reported improvement in insulin resistance and thereby intracellular glucose uptake after myo-inositol treatment in PCOS patients, but these studies have a small sample size, varying methodology, and outcome analysis. Therefore, we designed a present meta-analysis of randomized controlled trials to explore the effect of myo-inositol supplementation on anthropometric, metabolic, and endocrine outcomes in PCOS patients. Randomized controlled trials assessing the effectiveness of myo-inositol were identified in electronic databases like PubMed, Cochrane, Embase, MEDLINE, CINAHL, and AMED. Listed references and citations of related articles were also screened manually to identify additional studies. Research papers for which full-text copies were not available on scientific databases were procured from respective authors. Thereafter, data were extracted from included studies and analyzed using RevMan 5.3 of the Cochrane Collaboration. A total of 17 randomized controlled trials with 1083 PCOS patients were included in this meta-analysis. Among the 17 trials, 7 trials compared myo-inositol with folic acid, 8 trials compared myo-inositol with metformin, and 2 trials compared myo-inositol with oral contraceptives. No significant improvement in body mass index, waist-to-hip ratio, fasting insulin, fasting glucose, HOMA, LH, FSH, estradiol, sex hormone-binding globulin, dehydroepiandrosterone, and total testosterone levels were observed after myo-inositol treatment in PCOS patients except androstenedione and prolactin levels. Clinically significant improvement was not observed in anthropometric, metabolic, and endocrine outcomes after myo-inositol treatment in PCOS patients. However, heterogeneity between studies was high.

Overview

Integrity signals

Registry

Crossref · 10.1007/s43032-022-00933-y

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

3 retracted

Show all 59 references

Research works printed but not linked: 4

  1. Robert J, Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;9588:685–97.
  2. Kabel AM. Journal of pharmacological reports polycystic ovarian syndrome : insights into pathogenesis, diagnosis, prognosis, pharmacological and non-pharmacological treatment. J Pharmacol Rep. 2016;1:1–5.
  3. Facchinetti F, Orrù B, Grandi G, Unfer V. Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials. Gynecol Endocrinol. 2019;35:198–206. https://doi.org/10.1080/09513590.2018.1540578. · DOI · Paper page
  4. Dona G, Sabbadin C, Fiore C, Bragadin M, Giorgino FL, Ragazzi E, et al. Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome. Eur J Endocrinol. 2012;166:703–10. https://doi.org/10.1530/EJE-11-0840. · DOI · Paper page

Cited by

See all 17

Metadata

Authors
Jethaliya, H., Gajjar, N., Patel, V., Deshpande, S., & Patel, R.
Corresponding author
Patel, Roshni
Venue
Reproductive Sciences
Published
2022-04-27
Volume
29
Issue
8
Pages
2282-2298
ISSN
  • 1933-7191 (ISSN-L)
  • 1933-7205
OpenAlex
W4225100565
Cited by
17
References
59
Citations by year
2026: 3 · 2025: 4 · 2024: 7 · 2023: 3
FWCI
0.56
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Reproductive Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Keywords
myo-inositol, polycystic ovary syndrome, insulin resistance, insulin sensitivity, anthropometric outcomes, body mass index, waist-to-hip ratio, metabolic outcomes, endocrine outcomes, androstenedione, prolactin, sex hormone-binding globulin, testosterone, metformin, folic acid, oral contraceptives, female infertility
MeSH terms
Female, Folic Acid, Humans, Inositol, Insulin, Insulin Resistance, Metformin, Polycystic Ovary Syndrome, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of Myo-inositol on Anthropometric, Metabolic, and Endocrine Outcomes in PCOS Patients: a Meta-analysis of Randomized Controlled Trial. https://app.cochat.ai/papers/10.1007/s43032-022-00933-y
The paper
Jethaliya, H., Gajjar, N., Patel, V., Deshpande, S., & Patel, R. (2022). Efficacy of Myo-inositol on Anthropometric, Metabolic, and Endocrine Outcomes in PCOS Patients: a Meta-analysis of Randomized Controlled Trial. Reproductive Sciences. https://doi.org/10.1007/s43032-022-00933-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.